HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kimball, H. R. Articles by Wolff, S. M. Search for Related Content PubMed Articles by Kimball, H. R. Articles by Wolff, S. M.

Effect of Bacterial Endotoxin on Experimental Fungal Infections¹

United States Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Clinical Investigations, Bethesda 14, Maryland

Abstract

Escherichia coli endotoxin was administered to mice prior to challenge with 5 x 10⁶ Candida albicans, 5 x 10⁶ Rhizopus arrhizus or 1 x 10⁶ Blastomyces dermatitidis organisms. When 100 or 400 µg endotoxin was given 1 hr prior to challenge with C. albicans, significant acceleration in mortality occurred, while the same doses of endotoxin given 24 hr before challenge delayed lethality. Similar protection but no enhancement of lethality was noted for R. arrhizus, while reproducible alterations in lethality were not demonstrable with B. dermatitidis. Protection against C. albicans appeared to have a bimodal character, being maximal at 24 hr and 6 days following endotoxin administration. Sterile sera were passively administered in amounts of 1.0 ml to normal mice, which were then challenged 1 hr later with C. albicans. Lethality was significantly delayed only in the animals receiving sera collected 24 hr after endotoxin but not in the groups receiving saline, normal sera or sera obtained 6 days following endotoxin. These studies demonstrate that serum factors are important in the initial phase of increased resistance against C. albicans induced by endotoxin.

Footnotes

¹ Presented in part at the meeting of American Association of Immunologists, Chicago, Illinois, April 19, 1967.